131 related articles for article (PubMed ID: 12428204)
1. Nonclassic 21-hydroxylase deficiency.
Dewailly D
Semin Reprod Med; 2002 Aug; 20(3):243-8. PubMed ID: 12428204
[TBL] [Abstract][Full Text] [Related]
2. 21-hydroxylase-deficient nonclassic adrenal hyperplasia: the great pretender.
Moran C; Azziz R
Semin Reprod Med; 2003 Aug; 21(3):295-300. PubMed ID: 14593552
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of nonclassic adrenal hyperplasia (NCAH) in hyperandrogenic women.
Fanta M; Cibula D; Vrbíková J
Gynecol Endocrinol; 2008 Mar; 24(3):154-7. PubMed ID: 18335331
[TBL] [Abstract][Full Text] [Related]
4. Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women.
Carmina E; Dewailly D; Escobar-Morreale HF; Kelestimur F; Moran C; Oberfield S; Witchel SF; Azziz R
Hum Reprod Update; 2017 Sep; 23(5):580-599. PubMed ID: 28582566
[TBL] [Abstract][Full Text] [Related]
5. A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs.
Escobar-Morreale HF; Sanchón R; San Millán JL
J Clin Endocrinol Metab; 2008 Feb; 93(2):527-33. PubMed ID: 18000084
[TBL] [Abstract][Full Text] [Related]
6. Non-classic adrenal hyperplasia due to the deficiency of 21-hydroxylase and its relation to polycystic ovarian syndrome.
Pignatelli D
Front Horm Res; 2013; 40():158-70. PubMed ID: 24002412
[TBL] [Abstract][Full Text] [Related]
7. 21-Hydroxylase deficiency in female hyperandrogenism: screening and diagnosis.
Azziz R; Zacur HA
J Clin Endocrinol Metab; 1989 Sep; 69(3):577-84. PubMed ID: 2547827
[TBL] [Abstract][Full Text] [Related]
8. Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study.
Azziz R; Hincapie LA; Knochenhauer ES; Dewailly D; Fox L; Boots LR
Fertil Steril; 1999 Nov; 72(5):915-25. PubMed ID: 10561000
[TBL] [Abstract][Full Text] [Related]
9. Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome.
Falhammar H; Nordenström A
Endocrine; 2015 Sep; 50(1):32-50. PubMed ID: 26082286
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Russian women with hyperandrogenism.
Grodnitskaya E; Kurtser M
Hum Fertil (Camb); 2018 Dec; 21(4):281-287. PubMed ID: 28669219
[TBL] [Abstract][Full Text] [Related]
11. The prevalence of non-classic adrenal hyperplasia among Turkish women with hyperandrogenism.
Unluhizarci K; Kula M; Dundar M; Tanriverdi F; Israel S; Colak R; Dokmetas HS; Atmaca H; Bahceci M; Balci MK; Comlekci A; Bilen H; Akarsu E; Erem C; Kelestimur F
Gynecol Endocrinol; 2010 Feb; 26(2):139-43. PubMed ID: 19718570
[TBL] [Abstract][Full Text] [Related]
12. Adrenocortical hyperresponsivity to adrenocorticotropic hormone: a mechanism favoring the normal production of cortisol in 21-hydroxylase-deficient nonclassic adrenal hyperplasia.
Huerta R; Dewailly D; Decanter C; Knochenhauer ES; Boots LR; Azziz R
Fertil Steril; 2000 Aug; 74(2):329-34. PubMed ID: 10927053
[TBL] [Abstract][Full Text] [Related]
13. Non-classic congenital adrenal hyperplasia.
Kelestimur F
Pediatr Endocrinol Rev; 2006 Aug; 3 Suppl 3():451-4. PubMed ID: 17551465
[TBL] [Abstract][Full Text] [Related]
14. [Nonclassic congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency].
Jesić M; Jesić M; Sajić S; Maglajlić S; Necić S; Bojić V
Srp Arh Celok Lek; 2004 Oct; 132 Suppl 1():106-8. PubMed ID: 15615479
[TBL] [Abstract][Full Text] [Related]
15. Steroid biomarkers for identifying non-classic adrenal hyperplasia due to 21-hydroxylase deficiency in a population of PCOS with suspicious levels of 17OH-progesterone.
Oriolo C; Fanelli F; Castelli S; Mezzullo M; Altieri P; Corzani F; Pelusi C; Repaci A; Di Dalmazi G; Vicennati V; Baldazzi L; Menabò S; Dormi A; Nardi E; Brillanti G; Pasquali R; Pagotto U; Gambineri A
J Endocrinol Invest; 2020 Oct; 43(10):1499-1509. PubMed ID: 32236851
[TBL] [Abstract][Full Text] [Related]
16. Nonclassic Adrenal Hyperplasia (NCAH) due to 21-hydroxylase deficiency: A cohort of 78 patients.
Wan Z; Wang W; Zheng S; Han R; Xie X; Zhao Y; Wang W; Sun S; Ye L
J Steroid Biochem Mol Biol; 2023 Jan; 225():106192. PubMed ID: 36167262
[TBL] [Abstract][Full Text] [Related]
17. Steroid Screening Tools Differentiating Nonclassical Congenital Adrenal Hyperplasia and Polycystic Ovary Syndrome.
Maffazioli GDN; Bachega TASS; Hayashida SAY; Gomes LG; Valassi HPL; Marcondes JAM; Mendonca BB; Baracat EC; Maciel GAR
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32530459
[TBL] [Abstract][Full Text] [Related]
18. Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia.
Moran C; Azziz R; Weintrob N; Witchel SF; Rohmer V; Dewailly D; Marcondes JA; Pugeat M; Speiser PW; Pignatelli D; Mendonca BB; Bachega TA; Escobar-Morreale HF; Carmina E; Fruzzetti F; Kelestimur F
J Clin Endocrinol Metab; 2006 Sep; 91(9):3451-6. PubMed ID: 16822826
[TBL] [Abstract][Full Text] [Related]
19. NIH conference. Future directions in the study and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Merke DP; Bornstein SR; Avila NA; Chrousos GP
Ann Intern Med; 2002 Feb; 136(4):320-34. PubMed ID: 11848730
[TBL] [Abstract][Full Text] [Related]
20. The diagnosis of nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, based on serum basal or post-ACTH stimulation 17-hydroxyprogesterone, can lead to false-positive diagnosis.
Ambroziak U; Kępczyńska-Nyk A; Kuryłowicz A; Małunowicz EM; Wójcicka A; Miśkiewicz P; Macech M
Clin Endocrinol (Oxf); 2016 Jan; 84(1):23-9. PubMed ID: 26331608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
